Lung Cancer

Racial Disparities in Lung Cancer: Part 2 of a Special Series

By

Tori Rodriguez, MA, LPC, AHC

Publish Date January 12, 2021

In part 2 of this 3-part series, the recent State of Lung Cancer report by the American Lung Association, which included state-level and national-level data on lung cancer in people of color for the first time.

Racial Disparities in Lung Cancer: Part 1 of a Special Series

By

Tori Rodriguez, MA, LPC, AHC

Publish Date January 8, 2021

A sizable body of research has long shown racial disparities in treatment and survival between Black and White patients with lung cancer.

Tepotinib Yields High Partial Response Rates in NSCLC With MET Alterations

By

Agata Boxe

Publish Date October 26, 2020

The MET alteration occurs in 3% to 4% of patients with the condition.

Trilaciclib Now Available to Reduce Chemotherapy-Induced Bone Marrow Suppression in Extensive-Stage SCLC

The approval was based on data from 3 randomized, placebo-controlled trials that included 245 adults with ES-SCLC.

Early Blood-Based Detection of Lung Cancer Possible With Targeted Methylation Panels

Study data presented at the 2020 World Conference on Lung Cancer in Singapore illustrate the utility of a 10-marker methylation panel in lung cancer.

Nivolumab Significantly Improves Survival in Relapsed Malignant Mesothelioma

Dean Fennell, MBBS, PhD, presented data from a preliminary analysis of the phase 3 CONFIRM trial at the 2020 World Conference on Lung Cancer in Singapore.

Nab-Paclitaxel Inferior to Docetaxel in Previously Treated NSCLC

The aim of the phase 3 J-AXEL trial was to confirm nab-paclitaxel’s noninferiority to docetaxel in patients with previously treated non-small cell lung cancer (NSCLC).

CT-Guided Localization of Multiple Lung Modules Feasible With Microcoil Before VATS

Investigators evaluated the safety and feasibility of microcoil in simultaneous localization for multiple pulmonary nodules before video-assisted thoracic surgery (VATS).